ATE17441T1 - Inhalierbare arzneimittel, verfahren zu deren herstellung und pharmazeutische formulierungen diese enthaltend. - Google Patents

Inhalierbare arzneimittel, verfahren zu deren herstellung und pharmazeutische formulierungen diese enthaltend.

Info

Publication number
ATE17441T1
ATE17441T1 AT82200841T AT82200841T ATE17441T1 AT E17441 T1 ATE17441 T1 AT E17441T1 AT 82200841 T AT82200841 T AT 82200841T AT 82200841 T AT82200841 T AT 82200841T AT E17441 T1 ATE17441 T1 AT E17441T1
Authority
AT
Austria
Prior art keywords
particles
medicament
manufacture
processes
pharmaceutical formulations
Prior art date
Application number
AT82200841T
Other languages
English (en)
Inventor
Raymond Brian Forrester
Terence David Boardman
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Plc filed Critical Fisons Plc
Priority claimed from EP82200841A external-priority patent/EP0072046B1/de
Application granted granted Critical
Publication of ATE17441T1 publication Critical patent/ATE17441T1/de

Links

Landscapes

  • Medicinal Preparation (AREA)
AT82200841T 1981-07-24 1982-07-06 Inhalierbare arzneimittel, verfahren zu deren herstellung und pharmazeutische formulierungen diese enthaltend. ATE17441T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8122846 1981-07-24
EP82200841A EP0072046B1 (de) 1981-07-24 1982-07-06 Inhalierbare Arzneimittel, Verfahren zu deren Herstellung und pharmazeutische Formulierungen diese enthaltend

Publications (1)

Publication Number Publication Date
ATE17441T1 true ATE17441T1 (de) 1986-02-15

Family

ID=26084750

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82200841T ATE17441T1 (de) 1981-07-24 1982-07-06 Inhalierbare arzneimittel, verfahren zu deren herstellung und pharmazeutische formulierungen diese enthaltend.

Country Status (2)

Country Link
AT (1) ATE17441T1 (de)
ES (1) ES8400239A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9700136D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700134D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation

Also Published As

Publication number Publication date
ES514282A0 (es) 1983-10-16
ES8400239A1 (es) 1983-10-16

Similar Documents

Publication Publication Date Title
KR840000226A (ko) 신규한 형태의 의약품의 제조방법
DE69519157T2 (de) Inhalationszusammensetzungmit lactosegranulate
DE69635578T2 (de) Verfahren und system zur behandlung dispergierbarer feiner pulver
EP1007017B2 (de) Budesonid / formoterol formulierung zur inhalation mit einer bulkdichte zwischen 0,30 und 0,36 g/ml, verfahren zur herstellung der formulierung sowie anwendung derselben
JP3011770B2 (ja) 吸入適用のための製剤
CA2131285C (en) Pharmaceutical inhalation compositions
EG21484A (en) Composition for inhalation
US4199578A (en) Composition
RU97102349A (ru) Композиция для получения лекарственного средства (варианты) и способ ее получения
IE40616B1 (en) Apparatus for dispensing dosages of powdered medicaments by inhalation
ZA921659B (en) Low dose dry pharmaceutical preparations
HUP9801615A2 (hu) Szimetikon/vízmentes kalcium-foszfát-kompozíciók
RU2180563C2 (ru) Препарат для ингаляции, имеющий насыпную объемную плотность от 0,28 до 0,38 г/мл, содержащий будесонид
GB1520247A (en) Pelletised medicament formulations
DE69405580T2 (de) Verfahren zur herstellung von artzneiformulierungen
RU2180562C2 (ru) Препарат для ингаляции, имеющий насыпную объемную плотность 0,28 - 0,38 г/мл, содержащий тербуталина сульфат, способ его получения и его применение
ATE17441T1 (de) Inhalierbare arzneimittel, verfahren zu deren herstellung und pharmazeutische formulierungen diese enthaltend.
US5980949A (en) Formulation for inhalation
HUP0104975A2 (hu) Eljárás szilárd kiszerelési formájú gyógyszerek előállítására növényi kivonatból
DE3266072D1 (en) Method for the oral administration of substances in the form of liposomes, and relative pharmaceutical compositions
US3891749A (en) Digestive pharmaceutical composition comprising S-carboxymethyl cysteine for reducing viscosity of respiratory tract secretions, and method of treating therewith
JO1220B1 (en) Inhaled pharmaceutical preparations
ES455273A1 (es) Un metodo mejorado para la produccion de un compuesto medi- cinal, tal como una sal de 1,3-bis(2-carboxi-5-iloxi)propan-2-ol, en forma de pildoras o granulos blandos.
JPS571457A (en) Composition for separating blood serum or plasma
DE9307116U1 (de) Verfestigter Arzneistoffvorrat für die mechanische Erzeugung inhalierbarer Wirkstoffpartikel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked